Keywords: ratiopharm, challenges, glaxo, german, company, issued, challenge

RATIOPHARM CHALLENGES GLAXO

Article | 14 February 1994

Print This

- German company Ratiopharm has issued a challenge to Glaxo alleging that its Form 2 patent for Zantac (ranitidine) is not distinct ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in